Nanoparticles as carriers for nasal vaccine delivery

被引:86
作者
Köping-Höggård, M [1 ]
Sánchez, A [1 ]
Alonso, MJ [1 ]
机构
[1] Sch Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela 15782, Spain
关键词
chitosan; DNA; mucosal; nanoparticles; nasal; PLA; PLGA; vaccine;
D O I
10.1586/14760584.4.2.185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At present, there is considerable excitement within the nanotechnology field with regard to the potential use of nanosystems as carriers for mucosal vaccine delivery. Indeed, many of the vaccines available, including protein antigens and DNA vaccines, are very unstable and need to be protected from degradation in the biologic environment. In addition, their efficacy is limited by their poor capacity to cross biologic barriers and reach the target sites. As a consequence, the design of appropriate antigen carriers that could help overcome these problems has become a significant challenge. The goal of the present article is to review the recent advances in the design of polymeric nanosystems intended to be used as carriers for nasal vaccine delivery. More specifically, the authors present nanocarriers; that have been made of safe materials, such as biodegradable polyesters and polysaccharides. The information accumulated regarding the in vivo behavior of these nanocarriers indicates that they are able to facilitate the transport of the associated antigen across the nasal epithelium, thus leading to efficient antigen presentation to the immune system. Furthermore, the results suggest that not only the size and surface properties but also the polymer composition and the structural architecture of the nanosystems are critical for the optimization of these antigen carriers. In conclusion, future studies intended to provide increased knowledge regarding these properties and how they relate to the efficiency of the immune responses, will undoubtedly affect the design of new and more effective nasal vaccine delivery strategies.
引用
收藏
页码:185 / 196
页数:12
相关论文
共 68 条
[1]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[2]   Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery [J].
Alpar, HO ;
Somavarapu, S ;
Atuah, KN ;
Bramwell, V .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) :411-430
[3]  
Arai K., 1968, B TOKAI REGIONAL FIS, V56, P89
[4]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[5]   The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines [J].
Baudner, BC ;
Giuliani, MM ;
Verhoef, JC ;
Rappuoli, R ;
Junginger, HE ;
Del Giudice, G .
VACCINE, 2003, 21 (25-26) :3837-3844
[6]   Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis [J].
Beyer, WEP ;
Palache, AM ;
de Jong, JC ;
Osterhaus, ADME .
VACCINE, 2002, 20 (9-10) :1340-1353
[7]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[8]   Development of positively charged colloidal drug carriers: Chitosan coated polyester nanocapsules and submicron-emulsions [J].
Calvo, P ;
RemunanLopez, C ;
VilaJato, JL ;
Alonso, MJ .
COLLOID AND POLYMER SCIENCE, 1997, 275 (01) :46-53
[9]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[10]  
2-4